BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11245417)

  • 1. Age-associated risk of cancer among individuals with N-acetyltransferase 2 (NAT2) mutations and mutations in DNA mismatch repair genes.
    Frazier ML; O'Donnell FT; Kong S; Gu X; Campos I; Luthra R; Lynch PM; Amos CI
    Cancer Res; 2001 Feb; 61(4):1269-71. PubMed ID: 11245417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetyltransferase 2 influences cancer prevalence in hMLH1/hMSH2 mutation carriers.
    Heinimann K; Scott RJ; Chappuis P; Weber W; Müller H; Dobbie Z; Hutter P
    Cancer Res; 1999 Jul; 59(13):3038-40. PubMed ID: 10397239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication error in colorectal carcinoma: association with loss of heterozygosity at mismatch repair loci and clinicopathological variables.
    Johannsdottir JT; Bergthorsson JT; Gretarsdottir S; Kristjansson AK; Ragnarsson G; Jonasson JG; Egilsson V; Ingvarsson S
    Anticancer Res; 1999; 19(3A):1821-6. PubMed ID: 10470121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione S-transferase M1 associated with cancer occurrence in Korean HNPCC families carrying the hMLH1/hMSH2 mutation.
    Shin JH; Ku JL; Shin KH; Shin YK; Kang SB; Park JG
    Oncol Rep; 2003; 10(2):483-6. PubMed ID: 12579293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between family history and mismatch repair in colorectal cancer.
    Coggins RP; Cawkwell L; Bell SM; Crockford GP; Quirke P; Finan PJ; Bishop DT
    Gut; 2005 May; 54(5):636-42. PubMed ID: 15831908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unbalanced germ-line expression of hMLH1 and hMSH2 alleles in hereditary nonpolyposis colorectal cancer.
    Curia MC; Palmirotta R; Aceto G; Messerini L; Verì MC; Crognale S; Valanzano R; Ficari F; Fracasso P; Stigliano V; Tonelli F; Casale V; Guadagni F; Battista P; Mariani-Costantini R; Cama A
    Cancer Res; 1999 Aug; 59(15):3570-5. PubMed ID: 10446963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of mutations in mismatch repair genes in Portuguese families with hereditary non-polyposis colorectal cancer (HNPCC) by a multi-method approach.
    Fidalgo P; Almeida MR; West S; Gaspar C; Maia L; Wijnen J; Albuquerque C; Curtis A; Cravo M; Fodde R; Leitao CN; Burn J
    Eur J Hum Genet; 2000 Jan; 8(1):49-53. PubMed ID: 10713887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes.
    Thibodeau SN; French AJ; Roche PC; Cunningham JM; Tester DJ; Lindor NM; Moslein G; Baker SM; Liskay RM; Burgart LJ; Honchel R; Halling KC
    Cancer Res; 1996 Nov; 56(21):4836-40. PubMed ID: 8895729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decoding hereditary colorectal cancer.
    Boland CR
    N Engl J Med; 2006 Jun; 354(26):2815-7. PubMed ID: 16807419
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mutation of human mismatch repair genes in hereditary nonpolyposis colorectal cancer (HNPCC) families].
    Yuan Y; Huang J; Zheng S
    Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):105-7. PubMed ID: 11776847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.
    Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R
    N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of HNPCC: mutations of MMR genes.
    Papadopoulos N; Lindblom A
    Hum Mutat; 1997; 10(2):89-99. PubMed ID: 9259192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Germline mutation analysis in hMLH 1 and hMSH 2 genes in hereditary nonpolyposis colorectal cancer and colorectal cancer patients with familial history].
    Wang Y; Friedl W; Propping P
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Dec; 15(6):333-6. PubMed ID: 9845760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HNPCC syndrome, microsatellite instability and NF1 gene alteration].
    Puisieux A
    Bull Cancer; 1999 Oct; 86(10):812-4. PubMed ID: 10572231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mean age of tumor onset in hereditary nonpolyposis colorectal cancer (HNPCC) families correlates with the presence of mutations in DNA mismatch repair genes.
    Pensotti V; Radice P; Presciuttini S; Calistri D; Gazzoli I; Grimalt Perez A; Mondini P; Buonsanti G; Sala P; Rossetti C; Ranzani GN; Bertario L; Pierotti MA
    Genes Chromosomes Cancer; 1997 Jul; 19(3):135-42. PubMed ID: 9218993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetyltransferase (NAT) 2 acetylator status and age of onset in patients with hereditary nonpolyposis colorectal cancer (HNPCC).
    Pistorius S; Görgens H; Krüger S; Engel C; Mangold E; Pagenstecher C; Holinski-Feder E; Moeslein G; von Knebel Doeberitz M; Rüschoff J; Karner-Hanusch J; Saeger HD; Schackert HK;
    Cancer Lett; 2006 Sep; 241(1):150-7. PubMed ID: 16337339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnostics of cancer predisposition: hereditary non-polyposis colorectal carcinoma and mismatch repair defects.
    Bocker T; Rüschoff J; Fishel R
    Biochim Biophys Acta; 1999 May; 1423(3):O1-O10. PubMed ID: 10382540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Various mutation screening techniques in the DNA mismatch repair genes hMSH2 and hMLH1.
    Wahlberg S; Liu T; Lindblom P; Lindblom A
    Genet Test; 1999; 3(3):259-64. PubMed ID: 10495924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational germline analysis of hMSH2 and hMLH1 genes in early onset colorectal cancer patients.
    Montera M; Resta N; Simone C; Guanti G; Marchese C; Civitelli S; Mancini A; Pozzi S; De Salvo L; Bruzzone D; Donadini A; Romio L; Mareni C
    J Med Genet; 2000 Jul; 37(7):E7. PubMed ID: 10882759
    [No Abstract]   [Full Text] [Related]  

  • 20. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
    Aaltonen LA; Salovaara R; Kristo P; Canzian F; Hemminki A; Peltomäki P; Chadwick RB; Kääriäinen H; Eskelinen M; Järvinen H; Mecklin JP; de la Chapelle A
    N Engl J Med; 1998 May; 338(21):1481-7. PubMed ID: 9593786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.